Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Changes in the neutrophil to lymphocyte ratio as predictors of outcome in pediatric patients with central nervous system tumors undergoing surgical resection.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Flores-Bustamante, Al; Hernández-Regino, Laura; Castillejos-López, Manuel-De-Jesús; Martínez-Rodríguez, Daniel; Aquino-Gálvez, Arnoldo; Zapata-Tarrés, Marta; de Uña-Flores, Armando; Salinas-Lara, Citlaltepetl; Sierra-Vargas, Patricia; Torres-Espíndola, Luz María
- Source:
Cancer Biomarkers; 2022, Vol. 33 Issue 3, p291-298, 8p
- Subject Terms:
- Additional Information
- Abstract:
BACKGROUND: Changes in neutrophil to lymphocyte ratio (Δ NLR) have been used as a clinical tool for stratification and prognosis of patients with solid tumors, there is scarce evidence of their clinical relevance in patients with tumors of the central nervous system who have also undergone surgical resection. OBJECTIVE: Determine if (Δ NLR) are associated with poor response to treatment and worse prognosis in pediatric patients with central nervous system tumors (CNST) who underwent surgical resection. METHODS: We performed a retrospective cohort study; demographic, clinical, and hematological variables were evaluated, Kaplan-Meier survival curves and Cox proportional hazards regression model were performed to evaluate prognosis. RESULTS: The Δ NLR cutoff value obtained through the third interquartile range was 4.30; The probability of survival and complete response to treatment was different between patients with high Δ NLR when compared to patients with low Δ NLR (p = 0.013, p = ≪ 0.001, respectively). A high Δ NLR behaved as an independent predictor of worse Overall Survival (HR 2,297; 95% CI: 1,075–4.908, p = 0.032). CONCLUSION: An elevated Δ NLR was a predictor of poor response to treatment and a prognostic factor for worse Overall Survival in pediatric patients with CNST undergoing surgical resection. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Cancer Biomarkers is the property of IOS Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.